Once bullish on digital health, the pharmaceutical company Orexo has hit a wall ...
At an event highlighting past STAT Wunderkinds, one researcher spoke to the impo...
In a survey of patient advocacy groups, 52% thought brand-name pharma companies ...
More than half of patient groups surveyed in a new report say pharma isn't doing...
A bill against supervised drug use sites suggests U.S. attitudes toward harm red...
Surprising research suggests radiation may reprogram misfiring heart cells to co...
“I'm not hopeful because lockdowns seem like our new normal,” said one prisoner ...
In one study, researchers were able to avoid leg amputation in 75% of chronic li...
Researchers have developed a new plan to prevent more cases of preeclampsia, a l...
The company’s haematologic oncology portfolio generated $1.42bn in global net re...
The collaboration will combine Generate Biomedicines’ capabilities with MD Ander...
Tavros will gain the right to access OpenBench’s proprietary artificial intellig...
The company will use a portion of the funds to transition its first-in-class inv...
Abilify Asimtufii is a long-acting, extended-release injectable suspension offer...
Increased drug shortages, exposure of supply chain vulnerabilities by Covid-19, ...
Originally granted approval in the US, in 2017, Ozempic has subsequently obtaine...
